These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17175671)

  • 21. Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects.
    Evans DW; Salome CM; King GG; Rimmer SJ; Seale JP; Woolcock AJ
    Thorax; 1997 Feb; 52(2):136-42. PubMed ID: 9059473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD.
    Cazzola M; Califano C; Di Perna F; D'Amato M; Terzano C; Matera MG; D'Amato G; Marsico SA
    Respir Med; 2002 Oct; 96(10):790-5. PubMed ID: 12412978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
    Grönke L; Schlenker J; Holz O; Out TA; Magnussen H; Jörres RA
    Respir Med; 2005 Oct; 99(10):1241-8. PubMed ID: 16140224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sputum induction in COPD--it's safe, so now what do we do?
    Sutherland ER
    COPD; 2006 Jun; 3(2):73-4. PubMed ID: 17175668
    [No Abstract]   [Full Text] [Related]  

  • 26. The safety and success rate of sputum induction using a low output ultrasonic nebuliser.
    Hunter CJ; Ward R; Woltmann G; Wardlaw AJ; Pavord ID
    Respir Med; 1999 May; 93(5):345-8. PubMed ID: 10464902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyspnea assessment and adverse events during sputum induction in COPD.
    Makris D; Tzanakis N; Moschandreas J; Siafakas NM
    BMC Pulm Med; 2006 Jun; 6():17. PubMed ID: 16808839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Lung; 2006; 184(4):217-22. PubMed ID: 17006748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease.
    Reid DW; Soltani A; Johns DP; Bish R; Williams TJ; Burns GP; Walters EH
    Intern Med J; 2003 Dec; 33(12):572-7. PubMed ID: 14656230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED; van Dyk M; Sagriotis A
    Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
    Grootendorst DC; Gauw SA; Benschop N; Sterk PJ; Hiemstra PS; Rabe KF
    Pulm Pharmacol Ther; 2003; 16(6):341-7. PubMed ID: 14580925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of one method of sputum induction in asthmatic subjects.
    Wong HH; Fahy JV
    Am J Respir Crit Care Med; 1997 Jul; 156(1):299-303. PubMed ID: 9230765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Safety of sputum induction in interstitial lung disease].
    Sobiecka M; Kuś J
    Pneumonol Alergol Pol; 2008; 76(1):11-8. PubMed ID: 18283650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Bonay M; Bancal C; Crestani B
    Expert Opin Drug Saf; 2005 Mar; 4(2):251-71. PubMed ID: 15794718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
    Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
    J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.